Marketing-authorisation holder · Canada
Pfizer Canada Ulc
621 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
621 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 621
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABRILADA40 mg / 0.8 ml · Solution | Adalimumab | Canada | Marketed | 2022 |
| ABRILADA40 mg / 0.8 ml · Kit, Solution | Adalimumab | Canada | Authorised | |
| ABRILADA10 mg / 0.2 ml · Solution | Adalimumab | Canada | Authorised | |
| ABRILADA40 mg / 0.8 ml · Solution | Adalimumab | Canada | Marketed | 2022 |
| ABRILADA20 mg / 0.4 ml · Solution | Adalimumab | Canada | Marketed | 2023 |
| ABRYSVO60 mcg / 0.5 ml + 60 mcg / 0.5 ml · Kit, Powder For Solution | Rsv subgroup a stabilized prefusion f protein, Rsv subgroup b stabilized prefusion f protein | Canada | Marketed | 2024 |
| ADCETRIS50 mg / vial · Powder For Solution | Brentuximab vedotin | Canada | Marketed | 2013 |
| ADRIAMYCIN PFS2 mg / ml · Solution | Doxorubicin | Canada | Not marketed | 1995 |
| ALESSE 2120 mcg + 100 mcg · Tablet | Ethinyl estradiol, Levonorgestrel | Canada | Marketed | 1998 |
| ALESSE 2820 mcg + 100 mcg · Tablet | Ethinyl estradiol, Levonorgestrel | Canada | Marketed | 1998 |
| AMINOPHYLLINE INJECTION USP25 mg / ml · Solution | Aminophylline | Canada | Not marketed | 1981 |
| ARICEPT5 mg · Tablet | Donepezil | Canada | Marketed | 1997 |
| ARICEPT10 mg · Tablet | Donepezil | Canada | Marketed | 1997 |
| AROMASIN25 mg · Tablet | Exemestane | Canada | Marketed | 2000 |
| ARTHROTEC 5050 mg + 200 mcg · Tablet (Delayed-Release) | Diclofenac, Misoprostol | Canada | Marketed | 1993 |
| ARTHROTEC 7575 mg + 200 mcg · Tablet (Delayed-Release) | Diclofenac, Misoprostol | Canada | Marketed | 1996 |
| ATGAM50 mg / ml · Solution | Antilymphocyte immunoglobulin (horse) | Canada | Marketed | 1998 |
| BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP9 mg / ml · Solution | Sodium chloride | Canada | Marketed | 1951 |
| BACTERIOSTATIC WATER FOR INJECTION USP30 ml / 30 ml · Solution | Water | Canada | Marketed | 1952 |
| BACTERIOSTATIC WATER FOR INJECTION USP-PRE-FILLED SYRINGE99.1 % · Liquid | Water | Canada | Marketed | 1997 |
| BENEFIX1000 unit / vial · Powder For Solution | Coagulation factor ix | Canada | Marketed | 2007 |
| BENEFIX3000 unit / vial · Powder For Solution | Coagulation factor ix | Canada | Marketed | 2013 |
| BENEFIX250 unit / vial · Powder For Solution | Coagulation factor ix | Canada | Not marketed | 2007 |
| BENEFIX1500 unit / vial · Powder For Solution | Coagulation factor ix | Canada | Authorised | |
| BENEFIX500 unit / vial · Powder For Solution | Coagulation factor ix | Canada | Marketed | 2007 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 621 | 278 | 343 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.